Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.67 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.67 |
| ▸ | CES1 | P23141 | 2/20 | 0.65 |
| ▸ | CDC25A | P30304 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29418113 | 1.00 | ALDH1A1 (0.67) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL8863090 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL8863074 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL10731237 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL9626594 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL23731163 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL10725536 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL732925 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL8862943 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL6050334 | 0.98 | CES1 (0.68) | ALDH1A1ALDH2ALDH3A1CES1CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349678-B | Continuous industrial production method of N-alkyl-nitrophthalimide | 珠海派锐尔新材料有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-114349678-A | Continuous industrial production method of N-alkyl-nitrophthalimide | 珠海派锐尔新材料有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-112110846-A | N-aryl phthalimide derivative and preparation method and application thereof | 河北农业大学 | 2020-12-22 | — | — | CN | claimed |
| CN-108558736-A | The synthetic method of N- n-pentyl phthalimides | 仪征市海帆化工有限公司 | 2018-09-21 | — | — | CN | claimed |
| US-9895379-B2 | 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents | CASSIOPEA S.P.A. (IT) | 2018-02-20 | — | — | US | claimed |
| EP-1999186-A1 | POLYETHERSULFONE COMPOSITION, METHOD OF MAKING AND ARTICLES THEREFROM | Sabic Innovative Plastics IP B.V. (NL) | 2008-12-10 | — | — | EP | claimed |
| WO-2007112198-A1 | POLYETHERSULFONE COMPOSITION, METHOD OF MAKING AND ARTICLES THEREFROM | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2007-10-04 | — | — | WO | claimed |
| EP-1704176-A2 | POLYETHERSULFONE COMPOSITION, METHOD OF MAKING AND ARTICLES THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2006-09-27 | — | — | EP | claimed |
| WO-2005052029-A2 | POLYETHERSULFONE COMPOSITION, METHOD OF MAKING AND ARTICLES THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2005-06-09 | — | — | WO | claimed |
| WO-2000010976-A1 | SUBSTITUTED N-ARYL-PHTHALIMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-03-02 | — | — | WO | claimed |
| EP-0591861-B1 | Reactivity control in microcrystalline coupler dispersions | EASTMAN KODAK CO (US) | 1999-07-28 | — | — | EP | claimed |
| US-4167638-A | Process for production of 8-NHR quinolines | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1979-09-11 | — | — | US | claimed |
| US-20240336711-A1 | REAGENTS AND METHODS FOR ALIPHATIC CARBON-HYDROGEN BOND FUNCTIONALIZATION | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2024-10-10 | — | — | US | disclosed |
| CN-114349678-B | Continuous industrial production method of N-alkyl-nitrophthalimide | 珠海派锐尔新材料有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-116903517-A | Preparation method of 4-nitro-N-alkylphthalimide | 广东优巨先进新材料股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-11730746-B2 | 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure | CVIE THERAPEUTICS LIMITED (TW) | 2023-08-22 | — | — | US | disclosed |
| US-4106940-A | N-ALKYLPHTHALIMIDE DERIVATIVE OIL FORMER | AGFA-GEVAERT, A.G. (DE) | 1978-08-15 | — | — | US | disclosed |
| US-3989685-A | FROM PENICILLIN-1-OXIDE | SHINOGI & CO., LTD. (JA) | 1976-11-02 | — | — | US | disclosed |
| US-3987056-A | DISPROPORTIONATION OF N-ARYL-1,2,3,6-TETRAHYDROPHTHALIMIDES | PHILLIPS PETROLEUM COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
| US-3987056-A | DISPROPORTIONATION OF N-ARYL-1,2,3,6-TETRAHYDROPHTHALIMIDES | PHILLIPS PETROLEUM COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336711-A1 | REAGENTS AND METHODS FOR ALIPHATIC CARBON-HYDROGEN BOND FUNCTIONALIZATION | NCF1, SHROOM3, NPM1 | ALDH1A1 2010/4885ALDH2 421/4885ALDH3A1 949/4885 |
| US-11730746-B2 | 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure | CYP8B1, CYP24A1, NPPA | ALDH1A1 3110/4885ALDH2 3215/4885ALDH3A1 2355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.